SCHEMBL31678828

SCHEMBL31678828

CCc1nc2n(CC(=O)Nc3ccc(C(F)(F)F)cc3)c(C)c(-c3ccccc3)n2c(=O)c1-c1ccccc1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ TP53 P04637 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ FPR2 P25090 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ACHE P22303 2/20 0.36
▸ BACE1 P56817 2/20 0.36
▸ KDR P35968 1/20 0.36
▸ RORA P35398 1/20 0.36
▸ RORC P51449 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ KAT2B Q92831 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31678064 0.90 KDM4E (0.38) AKR1B1MAPTLMNAHTTMEN1
SCHEMBL31678790 0.88 AKR1B1 (0.40) AKR1B1MAPTTP53LMNAHTT
SCHEMBL31678842 0.87 KDR (0.37) AKR1B1MAPTTP53LMNAHTT
SCHEMBL31677840 0.84 MAPT (0.39) AKR1B1MAPTTP53LMNAHTT
SCHEMBL31678122 0.79 KMT2A (0.38) AKR1B1MAPTHTTMEN1KMT2A
SCHEMBL31678727 0.79 AKR1B1 (0.41) AKR1B1MAPTTP53MEN1KMT2A
SCHEMBL31678102 0.77 KDM4E (0.40) AKR1B1MAPTTP53MEN1KMT2A
SCHEMBL31677806 0.77 AKR1B1 (0.40) AKR1B1MAPTTP53LMNAMEN1
SCHEMBL31677890 0.75 ACHE (0.41) MAPTTP53LMNAMEN1KMT2A
SCHEMBL31653720 0.75 ALDH1A1 (0.42) AKR1B1MAPTTP53LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270218-A1 IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES AS WRN INHIBITORS INCYTE CORPORATION (US) 2025-08-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270218-A1 IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES AS WRN INHIBITORS WRN, RECQL, BLM AKR1B1 2350/4885MAPT 4574/4885TP53 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback